REDHILL BIOPHARMA
RedHill Biopharma is a pharmaceutical company focused primarily on acquisition and development of late clinical-stage new, improved and patented formulations of existing drugs, with preference to a 505(b)(2)* regulatory paths, as well as acquisition and developement of late clinical-stage, new and patented orphan drugs.
REDHILL BIOPHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.redhillbio.com
Total Employee:
51+
Status:
Active
Contact:
+972 3-541-3131
Total Funding:
252 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Current Advisors List
Advisor
Current Employees Featured
Dror Ben-Asher CEO, Director @ RedHill Biopharma
CEO, Director
Ori Shilo Co-Founder & Deputy CEO of Finance and Operations @ RedHill Biopharma
Co-Founder & Deputy CEO of Finance and Operations
June Almenoff Chief Sci, Officer @ RedHill Biopharma
Chief Sci, Officer
2015-03-01
Founder
Stock Details
Investors List
Kukbo
Kukbo investment in Post-IPO Equity - RedHill Biopharma
ROTH Capital Partners
ROTH Capital Partners investment in Post-IPO Equity - RedHill Biopharma
H. C. Wainwright & Co.
H. C. Wainwright & Co. investment in Post-IPO Equity - RedHill Biopharma
Nomura
Nomura investment in Post-IPO Equity - RedHill Biopharma
MLV & Co.
MLV & Co. investment in Post-IPO Equity - RedHill Biopharma
Yelin Lapidot Investment House
Yelin Lapidot Investment House investment in Post-IPO Equity - RedHill Biopharma
Migdal Insurance and Financial Holdings
Migdal Insurance and Financial Holdings investment in Post-IPO Equity - RedHill Biopharma
OrbiMed
OrbiMed investment in Post-IPO Equity - RedHill Biopharma
Broadfin Capital
Broadfin Capital investment in Post-IPO Equity - RedHill Biopharma
Fischer Pharmaceutical Laboratories Ltd
Fischer Pharmaceutical Laboratories Ltd investment in Venture Round - RedHill Biopharma
Official Site Inspections
http://www.redhillbio.com Semrush global rank: 2.08 M Semrush visits lastest month: 9.98 K
- Host name: 172.67.170.80
- IP address: 172.67.170.80
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "RedHill Biopharma"
RedHill Biopharma - About Us
RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering …See details»
RedHill Biopharma - Crunchbase Company Profile & Funding
Contact Email info@redhillbio.com Phone Number +972 3-541-3131 RedHill Biopharma specializes in the field of gastrointestinal and infectious diseases, constituting its primary areas …See details»
RedHill Biopharma - Investor Relations
RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering …See details»
RedHill Biopharma Ltd. Company Overview, Contact Details
Aug 21, 2024 John.Doe@redhillbio.com: 26%. Last@redhillbio.com: Doe@redhillbio.com: 7%. FirstLast@redhillbio.com: JohnDoe@redhillbio.com: 2%. See more formats. Frequently Asked …See details»
RedHill Biopharma Ltd. - LinkedIn
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal diseases and infectious diseases. RedHill’s U.S. commercial …See details»
RedHill Biopharma Ltd. - Company Profile & Staff Directory
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal diseases and infectious diseases. RedHill’s U.S. commercial …See details»
RedHill Biopharma Ltd. (RDHL) Company Profile & Overview
1 day ago RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia …See details»
Working At RedHill Biopharma: Company Overview and Culture
Redhillbio.com. Organization Type. Public. CEO. Dror Ben-Asher. Social Media. RedHill Biopharma, established in 2009, is a pharmaceutical company focused primarily on acquisition …See details»
RedHill Biopharma - Our Medicines
U.S. Commercial Office. 8311 Brier Creek Parkway Suite 105-161 Raleigh, NC 27617See details»
RedHill Biopharma - Home
About Us. Inspired by you, focused on your health, and driven to deliver. Learn MoreSee details»
Redhill Biopharma Ltd, RDHL:NAQ profile - FT.com - Financial Times
Dec 27, 2024 RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea.See details»
RedHill Biopharma Announces $8 Million Registered Direct Offering
Jan 25, 2024 RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into definitive agreements …See details»
RedHill Biopharma Announces Record Quarterly Revenues and …
Business update (unaudited and preliminary estimated fourth quarter financial data[1]): - Record Q4/2021 total net revenues estimated to be in the range of $22-24 million vs. $21.6 million in …See details»
Redhill Biopharma Ltd. - Cruelty Free Investing
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of …See details»
RedHill Biopharma - RedHill Biopharma to Host Fourth Quarter …
Mar 17, 2022 RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will report its fourth quarter and full year …See details»
RedHill Biopharma Announces First Half 2024 Business Highlights
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its first half 2024 financial results and operational …See details»
RedHill Biopharma Announces First Half 2024 Business Highlights
Aug 29, 2024 A transformed RedHill: Numerous potential catalysts Strengthened cash balance and control over our destiny following the Termination Agreement with Movantik Acquisition …See details»
Operational excellence in biopharma research and early …
8 hours ago Training talent to be innovative should extend beyond core skill sets to enable sound judgment for trade-off decisions. Asset teams should prioritize activities by evaluating …See details»
RedHill Biopharma - RedHill Biopharma Secures U.S. Government …
Oct 14, 2024 The U.S. government's Biomedical Advanced Research and Development Authority (BARDA) selected opaganib for joint development funding as a medical …See details»
RedHill Biopharma - RedHill Biopharma Announces Positive FDA …
FDA provided guidance on opaganib's regulatory pathway under the Animal Rule for Acute Radiation Syndrome (ARS) The FDA's Animal Rule allows for the use of pivotal animal model …See details»